The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Press release from Business Wire

Celgene Corporation to Present at Two Upcoming Investor Conferences

Wednesday, December 28, 2011

Celgene Corporation to Present at Two Upcoming Investor Conferences07:30 EST Wednesday, December 28, 2011 SUMMIT, N.J. (Business Wire) -- Celgene Corporation (NASDAQ: CELG) today announced its presentations at two upcoming investor conferences will be webcast live and will be available in the investor relations section of the company's Web site at Celgene management will provide an overview of the company. On Thursday, January 5, 2012, Celgene will present at the Goldman Sachs Healthcare CEOs Unscripted Conference at 3:15 p.m. ET. On Monday, January 9, 2012, Celgene will present at the 30th Annual J.P. Morgan Healthcare Conference at 11:00 a.m. ET. Celgene Corporation, headquartered in Summit, New Jersey, is an integrated global biopharmaceutical company engaged primarily in the discovery, development and commercialization of novel therapies for the treatment of cancer and inflammatory diseases through gene and protein regulation. For more information, please visit the company's Web site at This press release contains forward-looking statements, which are generally statements that are not historical facts. Forward-looking statements can be identified by the words "expects," "anticipates," "believes," "intends," "estimates," "plans," "will," “outlook” and similar expressions. Forward-looking statements are based on management's current plans, estimates, assumptions and projections, and speak only as of the date they are made. We undertake no obligation to update any forward-looking statement in light of new information or future events, except as otherwise required by law. Forward-looking statements involve inherent risks and uncertainties, most of which are difficult to predict and are generally beyond our control. Actual results or outcomes may differ materially from those implied by the forward-looking statements as a result of the impact of a number of factors, many of which are discussed in more detail in our Annual Report on Form 10-K and our other reports filed with the Securities and Exchange Commission. Celgene CorporationJacqualyn A. FouseSenior Vice President andChief Financial Officer908-673-9956orPatrick E. Flanigan IIIVice PresidentInvestor Relations908-673-9969